Reaction Details |
| Report a problem with these data |
Target | Beta-1 adrenergic receptor |
---|
Ligand | BDBM50092650 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_216046 (CHEMBL820722) |
---|
IC50 | 1900±n/a nM |
---|
Citation | Mathvink, RJ; Tolman, JS; Chitty, D; Candelore, MR; Cascieri, MA; Colwell, LF; Deng, L; Feeney, WP; Forrest, MJ; Hom, GJ; MacIntyre, DE; Miller, RR; Stearns, RA; Tota, L; Wyvratt, MJ; Fisher, MH; Weber, AE Discovery of a potent, orally bioavailable beta(3) adrenergic receptor agonist, (R)-N-[4-[2-[[2-hydroxy-2-(3-pyridinyl)ethyl]amino]ethyl]phenyl]-4-[4 -[4-(trifluoromethyl)phenyl]thiazol-2-yl]benzenesulfonamide. J Med Chem43:3832-6 (2000) [PubMed] |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Beta-1 adrenergic receptor |
---|
Name: | Beta-1 adrenergic receptor |
Synonyms: | ADRB1 | ADRB1R | ADRB1_HUMAN | B1AR | Beta-1 adrenoceptor | Beta-1 adrenoreceptor | adrenergic Beta1 |
Type: | G Protein-Coupled Receptor (GPCR) |
Mol. Mass.: | 51338.40 |
Organism: | Homo sapiens (Human) |
Description: | P08588 |
Residue: | 477 |
Sequence: | MGAGVLVLGASEPGNLSSAAPLPDGAATAARLLVPASPPASLLPPASESPEPLSQQWTAG
MGLLMALIVLLIVAGNVLVIVAIAKTPRLQTLTNLFIMSLASADLVMGLLVVPFGATIVV
WGRWEYGSFFCELWTSVDVLCVTASIETLCVIALDRYLAITSPFRYQSLLTRARARGLVC
TVWAISALVSFLPILMHWWRAESDEARRCYNDPKCCDFVTNRAYAIASSVVSFYVPLCIM
AFVYLRVFREAQKQVKKIDSCERRFLGGPARPPSPSPSPVPAPAPPPGPPRPAAAAATAP
LANGRAGKRRPSRLVALREQKALKTLGIIMGVFTLCWLPFFLANVVKAFHRELVPDRLFV
FFNWLGYANSAFNPIIYCRSPDFRKAFQGLLCCARRAARRRHATHGDRPRASGCLARPGP
PPSPGAASDDDDDDVVGATPPARLLEPWAGCNGGAAADSDSSLDEPCRPGFASESKV
|
|
|
BDBM50092650 |
---|
n/a |
---|
Name | BDBM50092650 |
Synonyms: | CHEMBL333417 | N-{4-[2-(2-Hydroxy-2-pyridin-3-yl-ethylamino)-ethyl]-phenyl}-4-[4-(2-trifluoromethyl-phenyl)-thiazol-2-yl]-benzenesulfonamide |
Type | Small organic molecule |
Emp. Form. | C31H27F3N4O3S2 |
Mol. Mass. | 624.696 |
SMILES | O[C@@H](CNCCc1ccc(NS(=O)(=O)c2ccc(cc2)-c2nc(cs2)-c2ccccc2C(F)(F)F)cc1)c1cccnc1 |
Structure |
|